1)Calamante F, Ganesan V, Kirkham FJ, Jan W, Chong WK, Gadian DG, Connelly A:MR perfusion imaging in moyamoya syndrome:potential implications for clinical evaluation of occlusive cerebrovascular disease. Stroke 32:2810-2816, 2001
2)Fujimura M, Shimizu H, Tominaga T:Transient focal neurological deficit due to hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Cereb Stroke (Jpn) 34:37-41, 2006
3)Furuya K, Kawahara N, Morita A, Momose T, Aoki S, Kirino T:Focal hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease. Case report. J Neurosurg 100:128-132, 2004
4)Houkin K, Ishikawa T, Yoshimoto T, Abe H:Direct and indirect revascularization for moyamoya disease:surgical techniques and peri-operative complications. Clin Neurol Neurosurg 99 Suppl 2:S142-145, 1997
5)Houkin K, Nonaka T, Baba T:Peri-operative complications in surgical treatment for moyamoya disease. Report by the Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease), 2004
6)Komoribayashi N, Ogasawara K, Kobayashi M, Saitoh H, Terasaki K, Inoue T, Ogawa A:Cerebral hyperperfusion after carotid endarterectomy is associated with preoperative hemodynamic impairment and intraoperative cerebral ischemia. J Cereb Blood Flow Metab 26:878-884, 2006 [Epub 2005 Nov 9]
7)Ogasawara K, Inoue T, Kobayashi M, Endo H, Fukuda T, Ogawa A:Pretreatment with the free radical scavenger edaravone prevents cerebral hyperperfusion after carotid endarterectomy. Neurosurgery 55:1060-1067, 2004
8)Ogasawara K, Komoribayashi N, Kobayashi M, Fukuda T, Inoue T, Yamada K, Ogawa A:Neural damage caused by cerebral hyperperfusion after arterial bypass surgery in a patient with moyamoya disease: case report. Neurosurgery 56:E1380, 2005
9)Ogasawara K, Yamadate K, Kobayashi M, Endo E, Fukuda T, Yoshida K, Terasaki K, Inoue T, Ogawa A: Postoperative cerebral hyperperfusion associated with impaired cognitive function in patients undergoing carotid endarterectomy. J Neurosurg 102:38-44, 2005
10)Sakamoto T, Kawaguchi M, Kurehara K, Kitaguchi K, Furuya H, Karasawa J:Risk factors for neurologic deterioration after revascularization surgery in patients with moyamoya disease. Anesth Analg 85:1060-1065, 1997
11)Shirane R, Yoshida Y, Takahashi T, Yoshimoto T:Assessment of EGMS with dural pedicle insertion in childhood moyamoya disease:characteristics of cerebral blood flow and oxygen metabolism. Clin Neurol Neurosurg 99 Suppl 2:S79-85, 1997
12)Sundt TM Jr, Sharbrough FW, Piepgras DG, Kearns TP, Messick JM Jr, O’Fallon WM:Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy:with results of surgery and hemodynamics of cerebral ischemia. Mayo Clin Proc 56:533-543, 1981
13)Suzuki J, Takaku A:Cerebrovascular ‘moyamoya’ disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288-299, 1969
14)Tanaka Y, Nariai T, Nagaoka T, Akimoto H, Ishiwata K, Ishii K, Matsushima Y, Ohno K:Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging-comparison with positron emission tomography. J Cereb Blood Flow metab 26:291-300, 2006
15)Wityk RJ, Hillis A, Beauchamp N, Barker PB, Rigamonti D:Perfusion-weighted magnetic resonance imaging in adult moyamoya syndrome:characteristic patterns and change after surgical intervention:case report. Neurosurgery 51:1499-1505, 2002